2005
DOI: 10.3892/ijmm.15.3.459
|View full text |Cite
|
Sign up to set email alerts
|

Endothelium dysfunction markers in patients with diabetic retinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
16
1
2

Year Published

2006
2006
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(21 citation statements)
references
References 0 publications
2
16
1
2
Order By: Relevance
“…However, it also has been reported that there are no differences in the VCAM-1 and ICAM-1 levels between diabetic patients with or without retinopathy (17,18). Furthermore, it has been reported that only the serum levels of VCAM-1 differ between diabetic patients with or without retinopathy, while the ICAM-1 levels are similar between these groups (27,28), or that only the ICAM-1 levels are increased, with similar VCAM-1 levels, in diabetic patients with retinopathy (22).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…However, it also has been reported that there are no differences in the VCAM-1 and ICAM-1 levels between diabetic patients with or without retinopathy (17,18). Furthermore, it has been reported that only the serum levels of VCAM-1 differ between diabetic patients with or without retinopathy, while the ICAM-1 levels are similar between these groups (27,28), or that only the ICAM-1 levels are increased, with similar VCAM-1 levels, in diabetic patients with retinopathy (22).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the serum levels of these molecules have been assessed in many studies; however, the results are not consistent (14)(15)(16)(17)(18).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We thus hypothesized that ExCO-C might also increase during LDLT and reflect the severity of tissue injury of the graft due to I/R. In this study, we examined time course changes of ExCO-C during LDLT, and studied their relationship with the serum levels of two important molecular markers of endothelial injury, namely, soluble thrombomodulin (sTM) and intercellular adhesion molecule (ICAM)-1 (16)(17)(18). Transplantation procedure.…”
Section: Introductionmentioning
confidence: 99%
“…22 vWF is a glycoprotein that is synthesized in the vascular endothelial cells and binds to coagulation factor VIII. 23 In the blood, it mediates platelet adhesion and aggregation to initiate thrombosis, and an increase of vWF is considered a sign of vascular endothelial cell injury. ET-1 is a powerful endogenous vasoconstrictor that influences the contraction of blood vessels and the proliferation of vascular SMCs.…”
Section: Discussionmentioning
confidence: 99%